So some readers will already have seen the article in today’s New York Times entitled “Cancer’s trick for dodging the immune system“. … READ MORE …
Filed under: Uncategorized | Tagged: cure, exosome, laboratory, mice, PD-L1 | 4 Comments »
So some readers will already have seen the article in today’s New York Times entitled “Cancer’s trick for dodging the immune system“. … READ MORE …
Filed under: Uncategorized | Tagged: cure, exosome, laboratory, mice, PD-L1 | 4 Comments »
Yet another set of researchers have found yet another possible new drug that seems to have significant activity in management of prostate cancer — in mice! Whether it will have activity in men is a whole other question. … READ MORE …
Filed under: Drugs in development, Management | Tagged: active, drug, investigational, IPA-3, mice | 4 Comments »
We have seen the ability of androgen deprivation to increase the efficacy of high dose IMRT in controlling prostate cancer (see this commentary). A new study from Johns Hopkins turns conventional logic on its head … READ MORE …
Filed under: Drugs in development | Tagged: androgen, bipolar, deprivation, mice, radiation, supplementation, therapy | 1 Comment »
Having pointed out (again) that over-use of many dietary supplements can increase risk for cancer (prostate cancer included), we felt it only fair to also point out that some recent data suggest than one over-the-counter (OTC) dietary supplement seems to have the opposite effect on prostate cancer … in laboratory mice. … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Prevention, Treatment | Tagged: 4-methylumbelliferone, 4-MU, mice, supplement | 7 Comments »
Data presented at the annual meeting of the American Society for Cancer Research suggest that a group of drugs called benzimidazoles may have activity in the treatment of advanced prostate cancer — at least in laboratory mice. … READ MORE …
Filed under: Drugs in development, Management | Tagged: activity, benzimidazole, mice | Leave a comment »